InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.
inSomaBio has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
inSomaBio's investors include National Science Foundation, Y Combinator, Asymmetry Ventures, North Carolina Biotechnology Center, CAV Angels.
inSomaBio is headquartered in Durham, United States.
InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.
inSomaBio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"inSomaBio — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/insomabio. Accessed July 21, 2026.
VCBacked. (2025). inSomaBio — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/insomabio
{{cite web |title=inSomaBio — Funding & Investors |url=https://www.vcbacked.co/company/insomabio |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated